These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2791279)

  • 1. Extending the detection limit of the TDx fluorescence polarization immunoassay for benzoylecgonine in urine.
    de Kanel J; Dunlap L; Hall TD
    Clin Chem; 1989 Oct; 35(10):2110-2. PubMed ID: 2791279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of TDx cocaine metabolite assay.
    Poklis A
    J Anal Toxicol; 1987; 11(5):228-30. PubMed ID: 3682784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of benzoylecgonine (cocaine metabolite) in urine: a cost-effective low risk immunoassay procedure.
    Moore FM; Simpson D
    Med Lab Sci; 1990 Apr; 47(2):85-9. PubMed ID: 2381273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evaluation of the Abbott TDx for benzoylecgonine and opiate screening in whole blood.
    McCord CE; McCutcheon JR
    J Anal Toxicol; 1988; 12(5):295-7. PubMed ID: 3066994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity testing of the TDx Cocaine Metabolite Assay with human specimens obtained after intravenous cocaine administration.
    Cone EJ; Menchen SL; Mitchell J
    Forensic Sci Int; 1988 Jun; 37(4):265-75. PubMed ID: 3410396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limit for qualitative detection of benzoylecgonine in urine using EMIT reagents and the Hitachi 705 automatic analyzer.
    Hall TD; Sanchez I; Dunlap L; de Kanel J
    J Anal Toxicol; 1989; 13(6):371-3. PubMed ID: 2691757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of cocaine and benzoylecgonine by derivatization with iodomethane-D3 or PFPA/HFIP in human blood and urine using GC/MS (EI or PCI mode).
    Aderjan RE; Schmitt G; Wu M; Meyer C
    J Anal Toxicol; 1993; 17(1):51-5. PubMed ID: 8429629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct stopped-flow fluorescence polarization immunoassay of abused drugs and their metabolites in urine.
    Pérez-Bendito D; Gómez-Hens A; Gaikwad A
    Clin Chem; 1994 Aug; 40(8):1489-93. PubMed ID: 8044987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPLC determination of cocaine and benzoylecgonine in plasma and urine from drug abusers.
    Fernández P; Lafuente N; Bermejo AM; López-Rivadulla M; Cruz A
    J Anal Toxicol; 1996; 20(4):224-8. PubMed ID: 8835659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results.
    Cone EJ; Sampson-Cone AH; Darwin WD; Huestis MA; Oyler JM
    J Anal Toxicol; 2003 Oct; 27(7):386-401. PubMed ID: 14606991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of immunoassay methods for the screening of cocaine metabolites in urine.
    Baugh LD; Allen EE; Liu RH; Langner JG; Fentress JC; Chadha SC; Cook LF; Walia AS
    J Forensic Sci; 1991 Jan; 36(1):79-85. PubMed ID: 2007883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency department evaluation of a rapid assay for detection of cocaine metabolites in urine specimens.
    Belfer RA; Klein BL; Boenning DA; Soldin SJ
    Pediatr Emerg Care; 1996 Apr; 12(2):113-5. PubMed ID: 8859922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of validity of the KDI Quik Test Drug Screen for detection of benzoylecgonine in urine.
    Cone EJ; Menchen SL
    J Anal Toxicol; 1987; 11(6):276-7. PubMed ID: 3431098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the USDT flow immunosensor for quantitation of benzoylecgonine in urine.
    Yu H; Kusterbeck AW; Hale MJ; Ligler FS; Whelan JP
    Biosens Bioelectron; 1996; 11(8):725-34. PubMed ID: 8639280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-reagent polarisation fluoroimmunoassay for the cocaine metabolite, benzoylecgonine, in urine.
    Colbert DL; Smith DS; Landon J; Sidki AM
    Ann Clin Biochem; 1986 Jan; 23 ( Pt 1)():37-41. PubMed ID: 3532909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity testing of commercial urine cocaine metabolite assays: I. Assay detection times, individual excretion patterns, and kinetics after cocaine administration to humans.
    Cone EJ; Menchen SL; Paul BD; Mell LD; Mitchell J
    J Forensic Sci; 1989 Jan; 34(1):15-31. PubMed ID: 2918277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of fluorescence polarization immunoassay, enzyme immunoassay, and thin-layer chromatography for urine cannabinoid screening. Effects of analyte adsorption and vigorous mixing of specimen on detectability.
    Dextraze P; Griffiths WC; Camara P; Audette L; Rosner M
    Ann Clin Lab Sci; 1989; 19(2):133-8. PubMed ID: 2546480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the radioimmunoassay for benzoylecgonine (a cocaine metabolite) in human urine.
    Mulé SJ; Jukofsky D; Kogan M; De Pace A; Verebey K
    Clin Chem; 1977 May; 23(5):796-801. PubMed ID: 322891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of an automated immunoassay based on kinetic interaction of microparticles in solution for determination of opiates and cocaine metabolite in urine.
    Smith FP; Lora-Tamayo C; Carvajal R; Caddy B; Tagliaro F
    Ann Clin Biochem; 1997 Jan; 34 ( Pt 1)():81-4. PubMed ID: 9022892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of common drug screen tests.
    Schwartz JG; Zollars PR; Okorodudu AO; Carnahan JJ; Wallace JE; Briggs JE
    Am J Emerg Med; 1991 Mar; 9(2):166-70. PubMed ID: 1994947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.